#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13726	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2079	653.6	0	.	n	.	0	C451T	SNP	451	451	C	680	680	T	771	T	724	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13726	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2079	653.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1413	1413	C	785	C	744	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25042	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3727	669.8	0	.	n	.	0	T695C	SNP	695	695	T	1008	1008	C	792	C,T	742,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25042	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3727	669.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2284	2284	C	796	C,T,G	744,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25042	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3727	669.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2358	2358	A	770	A	731	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25042	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3727	669.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2910	2910	C	747	C	712	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25042	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3727	669.8	0	HET	.	.	.	A1638G	.	1638	1638	A	1951	1951	A	897	A,G	691,157	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1874	folP	855	855	100.0	folP.l15.c4.ctg.1	1706	109.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1141	1143	AGC	197;193;194	A;G;C	187;184;183	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5154	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3323	154.6	1	SNP	p	S91F	1	.	.	271	273	TTC	566	568	TTC	197;199;199	T;T;C	183;185;184	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5154	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3323	154.6	1	SNP	p	D95G	1	.	.	283	285	GGC	578	580	GGC	193;194;194	G;G,C;C	180;182,1;182	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5154	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3323	154.6	1	SNP	p	G95N	0	.	.	283	285	GGC	578	580	GGC	193;194;194	G;G,C;C	180;182,1;182	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1442	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1397	102.8	1	SNP	p	G45D	0	.	.	133	135	GGC	520	522	GGC	172;175;177	G;G;C,T	161;161;162,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	758	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	930	80.1	0	.	n	.	0	A197.	DEL	197	197	A	480	480	A	169	A	163	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4792	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	163.0	1	SNP	p	D86N	0	.	.	256	258	GAC	539	541	GAC	228;229;227	G;A;C	208;203;210	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4792	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	163.0	1	SNP	p	R87W	0	.	.	259	261	CGT	542	544	CGT	226;227;227	C;G;T	208;208;205	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4792	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	163.0	1	SNP	p	R87I	0	.	.	259	261	CGT	542	544	CGT	226;227;227	C;G;T	208;208;205	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4792	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	163.0	1	SNP	p	S87R	1	.	.	259	261	CGT	542	544	CGT	226;227;227	C;G;T	208;208;205	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4792	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	163.0	1	SNP	p	S88P	0	.	.	262	264	TCC	545	547	TCC	226;225;225	T;C;C	202;202;204	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4010	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2517	157.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1486	1488	GGC	201;204;204	G;G;C	184;188;186	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4064	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2237	180.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1172	1174	GCC	194;196;193	G;C;C	175;174;175	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4064	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2237	180.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1175	1177	ATG	195;194;192	A;T;G	177;176;176	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4064	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2237	180.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1187	1189	ACC	191;191;191	A;C;C	174;175;174	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4064	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2237	180.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1187	1189	ACC	191;191;191	A;C;C	174;175;174	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4064	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2237	180.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1688	1690	ACC	204;203;201	A;C;C	184;187;188	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4064	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2237	180.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1742	1744	GCG	197;200;204	G;C;G	184;183;190	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4064	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2237	180.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1742	1744	GCG	197;200;204	G;C;G	184;183;190	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4064	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2237	180.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1865	1867	GGT	168;168;170	G;G;T	158;158;155	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4064	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2237	180.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1874	1876	AGC	164;163;162	A;G;C	154;151;149	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4064	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2237	180.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1892	1894	CCG	145;149;150	C,G;C,G;G	108,8;115,2;118	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5234	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3189	163.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1603	1605	CCG	194;196;197	C;C;G,C	168;181;177,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2114	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1644	126.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	505	505	C	150	C	135	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2576	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1730	148.4	0	.	p	.	0	G210R	NONSYN	628	630	GGA	969	971	AGA	224;223;224	A;G;A	216;213;216	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2576	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1730	148.4	0	.	p	.	0	S217G	NONSYN	649	651	AGT	990	992	GGT	222;223;222	G;G;T	214;215;211	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2576	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1730	148.4	1	SNP	p	G120K	1	.	.	358	360	AAG	699	701	AAG	188;188;189	A;A;G	176;176;173	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2576	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1730	148.4	1	SNP	p	A121N	1	.	.	361	363	AAC	702	704	AAC	191;191;189	A;A;C	178;178;178	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2576	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1730	148.4	1	SNP	p	N121D	0	.	.	361	363	AAC	702	704	AAC	191;191;189	A;A;C	178;178;178	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9648	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4823	199.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	964	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	882	107.6	1	SNP	p	V57M	1	.	.	169	171	ATG	441	443	ATG	195;194;193	A;T;G	183;183;182	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
